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Abstract: Objectives: To describe an individual with recurrent
respiratory papillomatosis that extended into the lung parenchyma
and underwent malignant transformation and to discuss the
characteristic imaging ﬁndings associated with this condition. Methods:
The clinical presentation of an individual with this unusual malignant
transformation was reviewed. A literature search was performed to
characterize the epidemiology, imaging ﬁndings and management of this
condition. Results: The patient underwent 30 courses of surgery over
21 years and presented disseminated pulmonary papilloma after
childbirth. The interval between dissemination into the lung and
malignant transformation was 2.5 years. The tracheal papilloma was
positive for type 6 of human papilloma virus (HPV-6). She died because
she refused further treatment. Conclusions: The clinician should have
a high index of suspicion for lung papillomatosis in patients with
a tracheotomy. Appropriate diagnostic imaging studies will be helpful in
reaching this diagnosis and determining whether a malignancy exists.
Treatment options have limited success when lung papillomatosis
becomes malignant.
Key Indexing Terms: Recurrent respiratory papillomatosis; Malignant;
Pulmonary; Pregnancy; HPV. [Am J Med Sci 2015;350(1):55–57.]
R ecurrent respiratory papillomatosis (RRP) is a rare disease inwhich multiple exophytic squamous wart-like lesions occur
within the larynx and the tracheobronchial tree.1 RRP is char-
acterized by an unpredictable course, varying from the sponta-
neous resolution of the papillomas to a rapid progression with
life-threatening airway obstruction and rarely leading to malig-
nant transformation of the lesions. Extension into the lung
parenchyma occurs in less than 1% of patients and is associated
with a low risk of malignant transformation.2 The treatment
options for intrapulmonary dissemination have limited success.
RRP with intrapulmonary dissemination portends a poor prog-
nosis.3 Here, we describe a case of juvenile-onset RRP that
progressed to carcinoma in a young adult who died of the
disease.
CASE REPORT
The patient was a woman who was born in 1985. She
was the ﬁrst child of her parents and was delivered at full term
by natural labor. Her mother denied a history of genital warts
during the pregnancy.
She was admitted to a local hospital in 1991 (when she
was 6 years old) for the ﬁrst time because of hoarseness. She
was diagnosed as having laryngeal papillomatosis and was
given an emergency tracheotomy. She underwent 14 courses of
surgery in the local hospital from then until October 2004 at
intervals of between 7 days and 5 years.
The patient was subsequently transferred to our hospital in
June 2005. She had respiratory distress for 1 month. A surgical
resection with a microdebrider was performed under general
anesthesia using suspension laryngoscopy. There was an anterior
commissural laryngeal web that was 1/3 the length of the vocal
cords. Diffuse papillomas were growing subglottic to the tracheal
stoma, with the most signiﬁcant ones being in the subglottic
region and near the tracheal stoma. The surgical specimens
diagnosed as laryngeal papilloma with type 6 of human
papilloma virus (HPV-6) tested by immunohistochemistry.
Subsequently, 8 endoscopic microdebrider ablations of
the papillomas were performed (in May 2006, March, July and
November of 2007 and February and May of 2008). Routine
preoperative chest radiographs showed no obvious abnormal-
ities. Many papillomas were distributed from the subglottic
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region to the tracheal stoma. The patient became pregnant in
November 2007, and a healthy baby girl was delivered by
caesarean section in August 2008.
The patient was admitted to our hospital in June 2009
because her trachea could not been blocked for 1 year. She had
no cough, hemoptysis, fever, dyspnea, weight loss, hematuria,
joint symptoms or rash. The chest x-ray performed before the
laryngeal surgery revealed a cystic lesion in the right midlung
zone. The operation showed that there was no signiﬁcant tumor
growth in the supraglottic region, and a bronchoscopy revealed
many papillomas growing in the trachea. A pale cauliﬂower-
like neoplasm that was growing in right main tracheal branch
indicated pulmonary metastasis of RRP.
A surgical microdebrider was used to remove the
tracheal papilloma in April 2010. A computed tomography
(CT) scan showed a nodule in the upper lobe of the right lung
and multiple cystic lesions in both lungs in June 2011. The
images demonstrated bronchiectasis with an infection. During
the surgery, after the removal of the tracheal papilloma lesions,
large pieces of the papilloma were found to block the right
superior bronchial segment. A postobstructive pneumonia was
present, and this was partially treated by removal of papillomas.
Full-length genome sequencing was performed on the
tissue specimen. Polymerase chain reaction reactions were
performed using Templiphi100 ampliﬁcation system. Sequenc-
ing of the long range polymerase chain reaction products was
performed at Huada (Shenzhen, China). The identiﬁcation of
HPV-6 genomic variants was made with BioEdit Sequence
Alignment Editor 7.0.9.0, and the sequence of prototype HPV-6
genome (GenBank Acc. No. M14119) was used as a standard
for comparison and genomic position numbering. The tracheal
papilloma was positive for HPV-6. There were 4 nonsynon-
ymous mutations, at bases 950 (E1, A to G), 1,322 (E1, C to G),
2,553 (E1, T to G) and 5,585 (L2, G to T). The mutant rates of
the 4 nonsynonymous mutations are all greater than 99% with
little signiﬁcance. The correlation of these mutations and
malignant transformation is unknown.
The CT scans that were performed in September and
November of 2011 showed that the nodule in the upper lobe of
the right lung had enlarged and that the number of round cystic
lesions had gradually increased in both lungs. In addition, many
enlarged lymph nodes were observed near the superior vena
cava and the right root of the neck. The lung biopsy revealed
differentiated squamous-cell carcinoma. For economic reasons,
the patient did not obtain further treatment for the lung cancer.
The patient underwent surgeries to remove the
endotracheal papilloma to relieve her difﬁculty in breathing
in January, February, March and June of 2012. The chest
x-ray in June 2012 revealed atelectasis of the right upper
lung lobe and an irregular tracheal wall. Multiple nodular
and cystic lesions of different thicknesses were visible in the
wall of the right lung (Figure 1). The CT scan performed at
the same time showed that the nodule in the upper lobe of
the right lung had enlarged, the cystic lesions in both lungs
had increased in the sizes of the lesions and many lymph
nodes in the mediastinum had grown (Figure 2). Some re-
sults of laboratory tests were abnormal, including the white
blood cell (12.5 3 109/L), hemoglobin (88 g/L), lactic acid
dehydrogenase (449 U/L) and highly-sensitive C reactive
protein (77.1 mg/L) results. The value of blood clotting
function, liver function, renal function and HIV tests was
normal. During surgery, after the removal of the papilloma
tissues that had almost completely blocked the airway,
copious purulent secretions poured from the right upper
bronchus. However, the pathological diagnosis of the
endotracheal lesions remained papilloma. The patient died
in December 2012.
DISCUSSION
RRP is one of the most common benign tumors of the
larynx in childhood. The distal trachea and bronchi are involved
in only 2% to 17% of patients, and 1% to 5% of patients show
pulmonary spread.4,5 The precise pathogenesis of the lung
involvement is unknown, although it is believed to result from
the aerial dissemination of fragments during endoscopic sur-
gery, with seeding of the lung tissue.2 Our patient had
FIGURE 1. Chest x-ray showing atelectasis in the right upper
lobe and the irregular appearance of the tracheal wall. Multiple
nodular and cystic lesions of different thicknesses are visible in the
walls of the right lung.
FIGURE 2. Axial CT image showing poststenotic atelectasis in
the right upper lobe with a central necrotic region. The main
tumor is in the center (arrow).
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disseminated pulmonary papilloma after childbirth. Whether the
changes in her hormone levels and immune status due to preg-
nancy were related to the metastasis and malignant transforma-
tion of the lung papillomas is unknown for the case is so rare.
Very few patients show malignant transformation of
pulmonary lesions.5 Malignant transformation into squamous-
cell carcinoma arises more often in older children or in young
adults than in younger children. The youngest child with RRP
to die of lung cancer was 6 years old, and 31% of such patients
were diagnosed before reaching adulthood (age: 18 years).6 Our
case involved juvenile-onset RRP that progressed to carcinoma
in young adulthood and became malignant. Our department
conducts approximately 300 surgeries on juvenile-onset RRP
patients through microlaryngoscopy every year. We conducted
316 surgeries on 176 patients with RRP in 2013, including
32 surgeries of 29 adult patients and 284 surgeries of 147
juvenile patients. Our patient had the only case involving the
conﬁrmed malignant transformation of pulmonary lesions into
squamous-cell carcinoma. In Gerein’s report, 7 malignant trans-
formation occurred in 66.7% of the patients with pulmonary
spread during the observation period (the interval between the
pulmonary spread of RRP and malignant transformation was
14.6 6 6.3 years). However, the interval time in our case was
only 2.5 years.
RRP may affect people of any age, but the age at disease
onset is considered to be the most important factor for the
prognosis of disease progression. In our case, the patient was
not very young, receiving her ﬁrst operation at the age of 6
years. She underwent 30 courses of surgery over 21 years,
which was not very frequent.
The course of the disease may be mild, with only a few
recurrences, or aggressive, with frequent recurrences and the
need for repeated excisions. There are no deﬁnitive explan-
ations for the variation in RRP outcomes, although the risk
factors for malignant transformation in RRP include smoking,
previous irradiation and the type of HPV present.7
In almost every patient with RRP, HPV DNA has been
identiﬁed, with the most common being HPV-6 and HPV-11.
The frequencies of individual HPV serotypes in juvenile-onset
papillomas have been reported to be 50% to 84% for HPV-6
and 25% to 37% for HPV-11.8,9 Several case reports have
described an association between HPV subtype 11 and malig-
nant transformation.4,10,11 Patients with subtype 11 are more
likely to be diagnosed at an earlier age, have more active dis-
ease and undergo more surgical procedures.11 HPV-11 is not
commonly associated with the development of invasive carci-
noma at other sites but has been correlated with malignant
transformation in the setting of juvenile onset recurrent respi-
ratory papillomatosis.4 The data from clinical cases indicated
that HPV-11 is associated with a greater risk of causing lung
cancer than HPV-6, although rarely HPV-6 can cause bronchial
carcinomas.12 Unfortunately, we did not take specimens of the
lung and tracheal papillomas to determine the differences in
their gene expression patterns.
The most evident CT features of pulmonary papilloma-
tosis are the following: (1) multiple solid and cystic nodules, (2)
atelectasis of the lobe secondary to airway obstruction, (3)
tracheal wall irregularities due to scarring and papillomas, (4)
bronchiectasis secondary to obstruction and chronic infection
and (5) superimposed secondary infectious changes with
parenchymal consolidation.13 If malignant transformation has
occurred, numerous enlarged lymph nodes will be observed
in the mediastinum and neck.
The treatment options have had limited success. Two
case reports of the use of cidofovir described some regression of
the pulmonary lesions.3,14 However, there is presently no cido-
fovir in China. Patients with RRP bear huge physical and men-
tal burdens and experience enormous economic pressures for
years. The malignant transformation of lung papilloma may
cause the patient to lose hope of a cure and to eventually forgo
treatment.
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